Wnt proteins are a large family of diffusible factors that play important roles in embryonic development, including axis patterning, cell fate specification, proliferation, and axon development. It was recently demonstrated that Ryk (receptor related to tyrosine kinase) is a conserved high-affinity Wnt receptor, and that Ryk-Wnt interactions guide corticospinal axons down the spinal cord during development. Here, we report that the Ryk-Wnt signal mediates the inhibition of corticospinal axon growth in the adult spinal cord. The expression of Wnt-5a is induced in reactive astrocytes around the injury site following a spinal cord injury. In vitro, Wnt-5a inhibits the neurite growth of postnatal cerebellar neurons by activating RhoA=Rho-kinase. In rats with thoracic spinal cord contusion, intrathecal administration of a neutralizing antibody to Ryk resulted in significant axonal growth of the corticospinal tract and enhanced functional recovery. Thus, reexpression of the embryonic repulsive cues in adult tissues contributes to the failure of axon regeneration in the central nervous system.
Introduction

I
n the adult mammalian central nervous system (CNS), it is well established that injured axons exhibit very limited regenerative ability. Due to the lack of appropriate axonal regeneration, traumatic damage to the adult brain and spinal cord frequently causes permanent neuronal deficits. After a CNS injury, various neurite outgrowth inhibitors are present around the damaged site and are considered to be, at least in part, responsible for lesion-induced poor axonal regeneration and functional deficits. Among these inhibitors, myelin-associated glycoprotein, Nogo, and oligodendrocytemyelin glycoprotein are well characterized (Yamashita et al., 2005) . Downstream of these inhibitors, the activation of RhoA and its effector Rho-associated serine=threonine kinase (Rho-kinase), after the binding of these inhibitors to the corresponding receptors, has been demonstrated to be a key element for axonal growth inhibition (Mueller et al., 2005) . In addition, recent publications propose roles for other proteins, including ephrin B3, Sema4D, and repulsive guidance molecule, in inhibiting axon regeneration following spinal cord injury (SCI) (Moreau-Fauvarque et al., 2003; Benson et al., 2005; Hata et al., 2006) . These proteins are well known for their ability to repel axons during the developmental stages. During the development of the nervous system, outgrowing axons are often required to travel long distances in order to reach their target neurons. In this process, outgrowing neurites tipped with motile growth cones rely on repulsive and attractive guidance cues present in their local environment. Therefore, cues that repel axons during the developmental stage may act as inhibitory molecules for injured axons in adults.
Members of the Wnt family of proteins are key regulators of pivotal developmental processes that include patterning, the specification of cell fate, and the determination of tissue polarity (Ciani et al., 2005; Zou, 2004) . In recent years, evidence has accumulated to suggest that Wnt proteins also play important roles in axon development during the formation of the nervous system (Zou, 2004) . Wnt proteins have been demonstrated to be bifunctional axon guidance molecules and several Wnt proteins appear to mediate guidance of corticospinal tract (CST) axons along the spinal cord via repulsion . Wnt-1 and Wnt-5a are expressed in the mouse spinal cord gray matter, cupping the dorsal funiculus, in an anterior-to-posterior decreasing gradient along the cervical and thoracic cord. These Wnt proteins repel CST axons in vitro through a conserved receptor, Ryk, which is expressed in the CST axons. The posterior growth of CST axons is blocked by a neutralizing antibody to Ryk, thereby establishing that Wnt proteins are repulsive guidance cues for developing CST axons. These findings increase the prospects of navigation for severed axons in adults, and provide evidence to suggest that some repulsive guidance cues act as inhibitors of axon growth.
In the present study, we assessed whether Wnt proteins act as inhibitors of axon growth in the adult spinal cord. The expression of Wnt-5a increased following thoracic SCI in rats. Importantly, using a function-blocking antibody, we provide evidence that Wnt-Ryk inhibition promotes axon growth and functional recovery following SCI.
Methods
All the experimental procedures were approved by the Institutional Committee of Chiba University.
Surgical procedure
Anesthetized (2% halothane) female Sprague-Dawley rats (200-250 gm) underwent a laminectomy at the T9=T10 vertebral level, thereby exposing the spinal cord. We contused the spinal cords with an Infinite Horizon Spinal Cord Impactor (Precision Systems and Instrumentation, Fairfax, VA). The impact force was set at 200 kdyn. In order to perform the neutralizing antibody treatment in the animal model, the rats were fitted with an osmotic minipump (200 ml, 0.5 ml=h, administered for 2 weeks; Alzet 2002; Durect Corp., Cupertino, CA) immediately after SCI. These pumps were filled with control rabbit immunoglobulin G (IgG; 26 animals, 13.0 mg=kg=day, over a 2-week period; Sigma, Saint Louis, MO) or an anti-Ryk antibody (21 animals, 13.0 mg=kg=day, over a 2-week period; Abgent, San Diego, CA). The anti-Ryk antibody was raised against the extracellular domain of Ryk. The minipump was placed under the skin on the animal's back, and a silastic tube connected to the outlet of the minipump was placed under the dura at the spinal cord contusion site with its tip immediately caudal to the injury site. Fibrin sealants (Beriplast; ZLB Behring, King of Prussia, PA) were allowed to drip on the dura in order to anchor the tube that was protruding from the dura. Thereafter, the muscle and skin layers were sutured. The bladder was evacuated by manual abdominal pressure at least twice a day until the bladder function was restored. Sham-operated rats (n ¼ 6) underwent laminectomy at the T9=10 vertebral level, thereby exposing their spinal cords. Minipumps that were filled with 0.85% saline and connected to silastic tubes were placed in three rats. Neither a minipump nor a silastic tube was placed in the other rats. Subsequently, the muscle and skin layers were sutured.
We used a section model to examine Wnt expression. The rats received a laminectomy at vertebral level T9=10, and the spinal cord was exposed. A no. 11 blade was used for the total section of the spinal cord, and the muscle and skin layers were sutured.
Tissue preparation and immunohistochemistry
For immunohistochemistry, tissues were obtained from an uninjured spinal cord and from spinal cords at 1, 3, and 7 days after the injury. After administering deep anesthesia using sodium pentobarbital, the animals were killed by perfusion with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. The animal's spinal cords were dissected, postfixed overnight in the same fixative, and cryopreserved in 20% sucrose in PBS. The spinal cord located 5 mm rostral and 5 mm caudal to the lesion site (10 mm long) was embedded in Tissue Tek OCT and immediately frozen in liquid nitrogen at -808C. In addition, transverse sections were also collected from the spinal cord 10 mm rostral to the injury site. Using a cryostat, a series of 50-mm parasagittal or transverse sections were cut and mounted on poly-l-lysine (PLL)-coated Superfrost-Plus slides (Matsunami, Osaka, Japan). The sections were washed three times with PBS, then blocked with PBS containing 5% bovine serum albumin (BSA) and 0.1% Triton X-100 for 1 h at room temperature. The sections were incubated overnight with primary antibody at 48C and washed three times with PBS. This was followed by incubation with fluorescein-conjugated secondary antibody (1:1000; Molecular Probes, Eugene, OR) for 1 h at room temperature. The anti-Wnt-5a antibody was prepared in rabbits by immunizing the animals with a synthetic peptide corresponding to the mouse Wnt-5a (Kurayoshi et al., 2006) . A monoclonal anti-GFAP antibody (1:200; Chemicon, Temecula, CA), the monoclonal antibody (Tuj1) that recognizes the neuron-specific b-tubulin III protein (1:500; Covance, Berkeley, CA), or the anti-Ryk antibody was used as the primary antibody.
Neurite outgrowth assay
Cerebellar granule neurons (CGNs) from postnatal rats pups (P6-P10) were dissociated by trypsinization (0.25% trypsin in PBS for 10 min at 378C), followed by resuspension FIG. 1. Wnt-5a is induced in astrocytes and microglia=macrophages after spinal cord injury (SCI). (A,B) Wnt-5a is expressed in rat spinal cord neurons. Fixed tissues were obtained for immunohistochemistry from sham-operated (control) adult rat spinal cords. Parasagittal sections were stained with the anti-Wnt-5a antibody, and double stained with the anti-Tuj1 antiWnt-5a antibody. Wnt-5a is expressed in the axons in the white matter and neuronal cell bodies in the gray matter. Insets of the left panel correspond to high-magnification views in the right panels (upper insets correspond to upper panels). (C,D) The sections were also double stained with the anti-Wnt-5a anti-glial fibrillary acidic protein (GFAP) antibody (C) or the antiWnt-5a anti-myelin=oligodendrocyte-specific protein (MOSP) antibody (D). Wnt-5a was not expressed in astrocytes or oligodendrocytes. (E) Double labeling with anti-Tuj1 and anti-Wnt-5a antibodies shows colocalization 1 day after SCI. (F,G) Double labeling with anti-GFAP and anti-Wnt-5a antibodies shows colocalization in the epicenter area at 1 day (F) and 7 days (G) after SCI. (H) Immunohistochemistry for Ryk. Axial sections of injured spinal cord 10 mm rostral to the lesion site were obtained at 7 days after SCI, and were immunostained with the anti-Ryk antibody. The immunoreactivity for Ryk was found in the ventral part of the dorsal column. An inset of the left panel corresponds to a high-magnification view of the dorsal corticospinal tract (CST) in the right panel. Scale bar ¼ 500 mm (left-side panels); 100 mm (right panel of H); 50 mm (others).
in a serum-containing medium, trituration, and three washes with PBS. The cultures were grown in serum-free Dulbecco's modified Eagle's medium (DMEM). For the soluble Wnt-5a assays, neurons were plated on a conditioned media on PLLcoated chamber slides (Lab-Tek; Nalge Nunc International, Rochester, NY) and incubated for 24 h. Wnt-5a proteins were purified to near homogeneity by three successive column chromatographies (Kishida et al., 2004; Kurayoshi et al., 2006) . The concentration of Wnt-5a were 90 ng=ml. Where indicated, 10 mM Y27632 (Mitsubishi Pharmaceuticals, Tokyo, Japan) was added to the cultures. For the neutralizing antibody assay, the anti-Ryk antibody (Abgent) was added to the culture at a concentration of 0.5 mg=ml. Where indicated, rat MAG-Fc chimera (25 mg=ml; R&D Systems), chicken extracellular chondroitin sulfate proteoglycans (CSPGs; the major components of this mixture are neurocans, phosphacan, versican, and aggrecan; Chemicon), or recombinant mouse RGMa (1 mg=ml; R&D Systems) were added. The cells were fixed in 4% (wt=vol) paraformaldehyde and immunostained with a monoclonal antibody (Tuj1) that recognized the neuron-specific b-tubulin III protein (1:1000; Covance). Subsequently, the length of the longest neurite for each b-tubulin III-positive neuron was determined. The neurite length of 100 neurons was measured for each experiment (n ¼ 3). 
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RhoA activity assay A G-LISA Rho activation assay kit (Cytoskeleton, Denver, CO) was used according to the manufacturer's recommendations. Where indicated, the cultures of the CGNs were incubated with Wnt-5a (90 ng=ml) for 10 min after which the cultures were grown in serum-free DMEM for 12-24 h. The protein concentrations of the cell lysates were equalized between 1.0 and 2.0 mg=ml. The surplus cell lysates were retained for further assay. The amount of the total Rho proteins was determined by western blotting using a monoclonal antibody against RhoA (Santa Cruz Biotechnology, Santa Cruz, CA).
Behavioral testing
Behavioral recovery was assessed in an open-field environment for 8 weeks after the injury by using the BassoBeattie-Bresnahan (BBB) locomotor rating scale (Basso et al., 1995) . Uninjured and sham-operated rats (n ¼ 6) achieved full scores. The quantification was performed in a blinded manner by two observers.
Anterograde CST labeling
Six weeks after injury, descending CST fibers were labeled with biotin dextran amine (BDA), 10% in saline, 2.0 ml per cortex (molecular weight [MW] of 10,000; Molecular Probes) that was injected in the left motor cortex under anesthesia (coordinates: 0.5-2.5 mm posterior to the bregma, 2 mm lateral to the bregma, 1.5-mm depth). For each injection, 0.5 ml BDA was delivered for a 30-s period via a 15-20-mm internal diameter glass capillary attached to a microliter syringe (Hamilton, Reno, NV). In total, we examined and compared the regenerative responses of four control and seven anti-Ryk antibody-treated rats after SCI. The animals were killed by perfusion with PBS followed by 4% paraformaldehyde 14 d after the BDA injection. The animal's spinal cords were dissected, postfixed overnight in the same fixative, and cryopreserved in 20% sucrose in PBS. The spinal cord located between 5 mm rostral and 5 mm caudal to the lesion site (10-mm long) was embedded in Tissue Tek OCT. These blocks were sectioned (50 mm) in the sagittal or transverse plane, retaining each section. In both cases, the transverse sections were also collected from the spinal cord located more than 5 mm rostral and caudal to the injury site (15 control and 13 anti-Ryk antibody-treated rats). We used the transverse sections for quantification, and the sagittal sections for the presentation of the images. These sections were incubated for 1 h with Alexa Fluor 488-conjugated streptavidin (1:400; Molecular Probes) in PBS containing 0.05% Tween-20.
Data analysis
Fifty-micrometer-thick transverse sections (four control and seven anti-Ryk antibody-treated rats) were evaluated. For each section, the number of intersections of BDA-labeled fibers was counted from 4 mm above to 4 mm below the lesion site. The axon number was calculated as the percentage of the fibers observed 4 mm above the lesion, where the CST was intact. The distance beyond the epicenter of the lesion was scored as a positive distance, whereas the other regions were scored as negative distances.
Results
Expression of Wnt-5a in the adult rat spinal cord
We first investigated the distribution pattern of Wnt proteins in the adult rat spinal cord. We performed immunohistochemistry on fixed sections of uninjured spinal cords. In the uninjured spinal cord of adult rats, immunoreactivity to Wnt-5a was observed in the white matter and the signal was colocalized with the immunoreactivity to neuron-specific ß-tubulin III protein (Tuj1) (Fig. 1A) , demonstrating that Wnt-5a was expressed in the spinal cord axons. The Wnt- 5a   FIG. 3 . The anti-Ryk antibody promotes locomotor recovery after spinal cord injury (SCI). The Basso-Beattie-Bresnahan (BBB) score was determined at the indicated times after thoracic contusion in the anti-Ryk antibody-treated (Anti-Ryk), control immunoglobulin G (IgG)-treated (Control), and sham-operated (Sham) rats. The mean AE standard error of the mean (SEM) of 21, 26, and six rats for each group, respectively. As indicated, the anti-Ryk antibody-treated group is statistically different from the control group. *P < 0.05 (Student's t-test) compared with the control.
immunoreactivity was also observed in the somata of Tuj1-positive neurons in the gray matter (Fig. 1B) . Double immunostaining with the anti-Wnt-5a antibody and an antibody against the glial fibrillary acidic protein (GFAP) revealed no colocalization, demonstrating that Wnt-5a was not present in astrocytes (Fig. 1C) . Double staining using anti-Wnt-5a anti-myelin=oligodendrocyte-specific protein (MOSP) antibodies demonstrated that Wnt-5a was not expressedin oligodendrocytes (Fig. 1D) . Thus, Wnt-5a was expressed in neurons in the adult rat spinal cord.
Expression of Wnt-5a is up-regulated following SCI
In order to address whether Wnt proteins play a role in pathogenesis after CNS injury, we examined Wnt-5a expression following SCI in rats. We performed immunohistochemistry on fixed sections obtained at 1, 3, and 7 days after injury at the T9=10 vertebral level. Immunoreactivity to Wnt-5a was induced around the injury site during the observation period following surgery. We performed a double-label experiment after the injury to characterize the Wnt-5a-expressing cells. GFAP-positive and Wnt-5a-positive cells were detected in the epicenter area 1 day (Fig. 1F ) and 7 days (Fig. 1G) after SCI, suggesting that Wnt-5a is expressed in the reactive astrocytes at the lesion epicenter. Immunoreactivity to Wnt-5a was observed in the white matter and the signal was colocalized with the immunoreactivity to Tuj1 (Fig. 1E) . We did not observe MOSP-positive=Wnt-5a-positive cells in the lesion epicenter or in the adjacent white matter (data not shown), suggesting that oligodendrocytes do not express Wnt-5a.
We then obtained axial sections from injured spinal cord 10 mm rostral to the lesion site and assessed whether one of the receptors for Wnts (Ryk) was expressed in the spinal cord. The immunoreactivity for Ryk was found in the ventral part of the dorsal column-where the dorsal CST runs-at 7 days after SCI (Fig. 1H) , although we found no significant immunoreactivity for Ryk in the dorsal column in the shamoperated rats (data not shown). These findings suggest that Ryk was expressed in the proximal axons of the CST after injury, which is consistent with the previous report (Liu et al., 2008) .
Wnt-5a inhibits neurite outgrowth by a mechanism dependent on Ryk in vitro
A possible role of Wnt proteins in the pathogenesis of SCI is that they contribute to axonal inhibition. In order to address this hypothesis in vitro, we employed CGNs obtained from postnatal rats (P6-P10). These cells are frequently used for studying the function of the molecules that inhibit neurite growth (Yamashita et al., 2005) . Although neurons from the adult cerebral cortex may be the optimal system for this type of study, to date we have been unsuccessful in culturing these neurons in vitro. For use in this assay, the Wnt-5a protein was purified to near homogeneity by three successive column chromatographies (Kishida et al., 2004; Kurayoshi et al., 2006) . The CGNs from postnatal rats were cultured on PLL-coated slides in the presence or absence of Wnt-5a. At a concentration of 90 ng=ml, Wnt-5a significantly inhibited the neurite outgrowth of the CGNs (Fig. 2A,B) . This inhibitory effect depended on Rho-kinase since the treatment of the CGNs with 10 mM Y27632-a specific inhibitor of Rho-associated protein kinase p160 ROCK (Uehata et al., 1997)-attenuated the effect of Wnt-5a, whereas Y27632 alone had no effect on neurite growth ( Fig. 2A,B) . To our knowledge, this is the first report to suggest that Wnt-5a inhibits neurite outgrowth, presumably by activating RhoA=Rho-kinase. Therefore, to directly assess whether RhoA is involved in the effect of Wnt-5a, the activity of RhoA was determined using the RhoA-binding domain of the effector protein, Rhotekin (Ren et al., 1999) and the G-LISA assay system (Fig. 2C) . The assay revealed that, within 10 min of the addition of soluble Wnt-5a, extracts of the cells contained increased amounts of GTP-RhoA compared to those of the control cells. These results strongly suggest that Wnt-5a inhibits neurite outgrowth by a mechanism dependent on the activation of the RhoA=Rho-kinase pathway.
Ryk is a high-affinity receptor for Wnt-1, Wnt-3a, and Drosophila Wnt-5 (Yoshikawa et al., 2003; Lu et al., 2004) . Ryk has been demonstrated to transmit repulsive signals in neurons Schmitt et al., 2006; Keeble et al., 2006) . This receptor is expressed in CGNs at a corresponding age (P6-P10) (Kamitori et al., 1999) . These findings prompted us to examine whether Ryk is involved in the Wnt-mediated inhibition of CGN neurite growth. We used a polyclonal antibody for the ectodomain of Ryk (anti-Ryk) and tested whether the anti-Ryk antibody could block Wnt-5a-mediated inhibition. We observed that the addition of the anti-Ryk antibody (0.5 mg=ml) efficiently blocked the inhibitory effects of Wnt-5a at a concentration of 90 ng=ml ( Fig. 2A,B) , whereas the anti-Ryk antibody alone had no effect on neurite growth. However, the anti-Ryk antibody (0.5 mg=ml) did not influence the inhibitory effect of other neurite growth inhibitors, including MAG, RGMa, or CSPG (Fig. 2D) , demonstrating the specificity of this neutralizing antibody. Therefore, Ryk is required for the inhibitory effect of Wnt-5a on CGN neurite growth.
Ryk neutralization leads to functional improvement
The binding of Wnts to Ryk repels CST axons during the developmental stages both in vitro and in vivo , and Ryk is expressed in the CST of adult rats after SCI (Fig.  1X,Y) . The above-mentioned results suggest the possibility that Wnt proteins, by virtue of their ability to inhibit neurite outgrowth, act as a barrier to the regrowth of injured axons after SCI, and that the blockage of these proteins may enhance recovery after SCI. We employed a rat spinal contusion model since this is relevant to clinical conditions. The spinal cords at the thoracic level (Th9=10) were contused by an impactor. The anti-Ryk antibody or a rabbit IgG control was administered for 2 weeks via osmotic minipumps connected to intrathecal catheters placed near the thoracic injury site. The locomotor performance of the animals was monitored over an 8-week period after the injury. The sham-operated rats (Fig. 3) achieved full scores according to the BBB locomotor rating scale (Basso et al., 1995) . All rats with a SCI became almost completely paraplegic from days 1-3 after the injury. As indicated by their BBB scores, these animals gradually exhibited partial recovery of locomotor behavior (Fig. 3) . At 2-8 weeks after the injury, the locomotor performance of rats treated with the anti-Ryk antibody tended to exhibits a better recovery than in those treated with the control IgG. On average, the control IgG-treated rats attained a BBB score of 12.0, whereas those treated with the anti-Ryk antibody achieved a significantly higher BBB score of 14.2 at 8 weeks after the surgery (Fig. 3) . Thus, the anti-Ryk antibody treatment significantly improved locomotor recovery following the spinal cord contusion in rats.
Ryk inhibition induces growth of injured corticospinal fiber tracts
Finally, we examined whether Wnt-Ryk signaling contributes to the inhibition of axon regeneration=sprouting after the SCI. The integrity of the dorsal CST in previously tested rats was assessed by injecting BDA into the unilateral sensorymotor cortex. The total number of labeled fibers located 10 mm above the lesion was not different between the antiRyk antibody-treated and the control IgG-treated rats (Fig.  4A,C,E,G,I ), thus indicating that the extent of BDA uptake was identical between the groups. For a group of animals (four control and seven anti-Ryk antibody-treated rats), blocks that extended 5 mm rostral and 5 mm caudal to the center of the injury were sectioned in the sagittal plane (Fig. 4B,F) . It is notable that labeled fibers with typical irregular meandering growth patterns were frequently observed in the tissue caudal to the lesion in the anti-Ryk antibody-treated rats (Fig. 4B,D) , whereas no BDA-labeled CST fibers were detected in the control IgG-treated rats (Fig. 4F,H) . We then reconstructed the transverse sections of the injured spinal cord and estimated the number of labeled fibers. Compared to the number of labeled fibers that were observed 4 mm rostral to the lesion site, more than 20% of the labeled fibers were observed 1-2 mm caudal to the lesion epicenter in the anti-Ryk antibody-treated rats. However, only a small percentage of the labeled fibers (0% at 1 mm and 3% at 2 mm caudal to the injury site) were observed in the control IgG-treated rats (Fig. 4J) . Labeled fibers were detected in the gray matter of injured animals treated with the anti-Ryk antibody (Fig. 4D) . Since we observed no labeled fibers in the normal locations of the dorsal CST caudal to the lesion site in any of the injured rats (data not shown), the increase in the labeled fibers after the anti-Ryk antibody treatment was not due to an increased survival of the dorsal CST.
Thus, these results demonstrate that treatment with the antiRyk antibody promoted significant fiber growth from the intact ventral CST or the injured dorsal CST after SCI. Ryk appears to mediate the inhibition of CST axon growth following SCI.
Discussion
Our study demonstrates that Wnt-5a was induced in the reactive astrocytes surrounding the site of injury after SCI in rats. Importantly, continuous infusion of the anti-Ryk antibody by osmotic minipumps resulted in the enhancement of the locomotor activity as well as the sprouting of the labeled CST. As our in vitro data demonstrate that neurite growth inhibition mediated by Wnt-5a is dependent on Rho-kinase, and that Wnt-5a activated RhoA in the CGNs, it is suggested that RhoA=Rho-kinase plays a role in the Wnt-mediated inhibition of axon growth in vivo.
Intracellular signals of axon growth inhibitors converge at RhoA and Rho-kinase
Several proteins in the CNS have been identified as inhibitors of axonal regeneration following the injury to the CNS in adult vertebrates. Three major inhibitors, Nogo, myelinassociated glycoprotein, and oligodendrocyte-myelin glycoprotein-expressed by oligodendrocytes and myelinated fiber tracts-have been identified (Yamashita et al., 2005) . All these inhibitors were observed to bind to the Nogo receptor in complex with p75 or TROY, members of the TNF receptor family, and LINGO-1. The ligands binding to this receptor complex induce activation of RhoA and Rho-kinase and this signal transduction is necessary for axonal growth inhibition, at least in vitro (Mueller et al., 2005) . Other studies have demonstrated that neurite outgrowth inhibitors, such as CSPG, and members of the semaphorin, ephrin, and repulsive guidance molecule families, also utilize the RhoA=Rho-kinase pathway for their inhibitory functions (Mueller et al., 2005) . Our study demonstrates that the inhibitory effects of Wnt-5a depended on Rho-kinase in vitro, and that RhoA was activated in the CGNs when treated with Wnt-5a. Previous observations have demonstrated that these Wnts signal through RhoA and Rho-kinase. Activation of Rho-kinase by Wnt-3a induces neurite retraction from N1E-115 neuroblastoma cells (Kishida et al., 2004) . Furthermore, a genetic study using zebrafish embryos demonstrated that the disruption of convergence and extension movement in Wnt-5 or Wnt-1 mutants was rescued by ectopic expression of RhoA or Rho-kinase, suggesting that RhoA=Rho-kinase act downstream of these Wnts (Zhu et al., 2005) . Therefore, Wnt proteins expressed in cells surrounding the injured site may limit axon growth by activating RhoA=Rho-kinase in the neurons after SCI. Our findings suggest new candidates for the role of inhibitors of axon regeneration, which presumably employ common signaling.
Glial cells express axon growth inhibitors
In this study, we observed the induced expression of Wnt-5a in the reactive astrocytes surrounding the injury site 8 MIYASHITA ET AL.
after SCI. CNS myelin derived from oligodendrocytes was first postulated as a major source of inhibition and several myelin-associated components that can inhibit axon outgrowth in vitro have been identified. In addition to the three above-mentioned myelin-derived inhibitors, the transmembrane semaphorin 4D (Moreau-Fauvarque et al., 2003) , ephrin B3 (Benson et al., 2005) , and repulsive guidance molecule (Hata et al., 2006) were proposed as members of the myelinderived inhibitors. It is clear that CNS myelin exerts multiple layers of inhibitory influences in vivo as well as in vitro (Yamashita et al., 2005) , although the extent of the relative contribution of each molecule remains to be determined. In addition to myelin, another important source of inhibition is the glial scar that forms after CNS injury. Many astrocytes in the injured area often become hypertrophic and adopt a reactive phenotype, releasing CSPG (McKeon et al., 1991) . After injury, CSPG expression is rapidly up-regulated by reactive astrocytes, forming an inhibitory gradient that is highest at the center of the lesion. The intrathecal administration of chondroitinase ABC-an enzyme that removes GAG chains from the protein core-following SCI promoted the regeneration of various axon tracts as well as functional recovery (Bradbury et al., 2002; Moon et al., 2001 ). In addition, mutant mice that are deficient in both GFAP and vimentin exhibit reduced astroglial reactivity and this results in supraspinal sprouting and functional recovery after SCI (Menet et al., 2003) , supporting the supposition that astrocytes may contribute to the inability of the injured spinal cord to regenerate. Therefore, our data, in combination with these findings, suggest that multiple inhibitors expressed in the reactive astrocytes, as well as myelin from the oligodendrocytes, may constitute a barrier that inhibits axon sprouting and functional recovery.
Multiple molecular targets for the treatment of SCI Liu et al. (2008) reported that Wnt1 and Wnt5a were induced in the gray matter after unilateral hemisection of the spinal cord. Ryk was also induced in the CST axons. Injection of function blocking antibody to Ryk into the dorsal bilateral hemisectioned spinal cord prevented the retraction of CST axons or promoted growth of CST. Our results are consistent with these observations, although we have novel data, including in vitro experiments. Importantly, we observed improvement of the locomotor function after spinal contusion, which is more relevant to clinical conditiones, by the anti-Ryk antibody treatment. Although a growing number of candidate molecules are suggested to be implicated in the inhibition of the regeneration of injured CNS axons, the extent of the relative contribution of each molecule remains to be determined. Combination therapies designed to target multiple inhibitors may be more effective than those that target an individual component. As many of these inhibitors utilize common signals, such as RhoA=Rho-kinase, for axon growth inhibition, it may be postulated that the inhibition of RhoA or Rho-kinase would be one of the most effective approaches for the treatment of SCI patients. Indeed, the pharmacological inhibition of RhoA or Rho-kinase has been demonstrated to promote axon growth and locomotor activity (Dergham et al., 2002; Fournier et al., 2003; Hara et al., 2000; Sung et al., 2003; Tanaka et al., 2004 ). However, it should be noted that pharmacological inhibitors are not cell type specific and, therefore, act not only on neurons but also on other cell types, including astrocytes and oligodendrocytes. Anti-Ryk antibody treatment for the first 2 weeks was sufficient in our study, and this is the case for the Rho-kinase inhibitor treatment (Tanaka et al., 2004) . Therefore, there seems to be some critical therapeutic period for the treatment of SCI. It is important to elucidate the whole network of the signal transduction mechanism of axon growth inhibition; therefore, our study provides evidence for a promising molecular target for the treatment of SCI.
Our observations strongly suggest that Wnt-Ryk signalling contributes significantly to the inability of the adult CNS to regenerate after injury. Although the CST axons are propelled down the spinal cord by a gradient of Wnt-1 and Wnt-5a acting through Ryk during the developmental stage, the severed CST axons in adults are stunted by the Wnt-Ryk signalling. The anti-Ryk antibody provides an effective therapeutic strategy for the treatment of CNS injury.
